Edition:
United Kingdom

Rocket Pharmaceuticals Inc (RCKT.OQ)

RCKT.OQ on NASDAQ Stock Exchange Global Market

20.51USD
21 Aug 2018
Change (% chg)

$0.19 (+0.94%)
Prev Close
$20.32
Open
$20.47
Day's High
$20.83
Day's Low
$20.30
Volume
42,382
Avg. Vol
101,021
52-wk High
$24.20
52-wk Low
$3.77

Chart for

About

Rocket Pharmaceuticals, Inc., formerly Inotek Pharmaceuticals Corporation, is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. Its lead product candidate, trabodenoson, is a selective adenosine mimetic... (more)

Overall

Beta: --
Market Cap(Mil.): $70.77
Shares Outstanding(Mil.): 27.01
Dividend: --
Yield (%): --

Financials

  RCKT.OQ Industry Sector
P/E (TTM): -- 85.69 32.76
EPS (TTM): -1.53 -- --
ROI: -40.76 1.78 14.61
ROE: -54.04 3.28 16.33

Rocket-control glitch delays launch of NASA's planet-hunting satellite

CAPE CANAVERAL, Fla. An 11th-hour technical glitch prompted SpaceX to postpone its planned launch on Monday of a new NASA space telescope designed to detect worlds beyond our solar system, delaying for at least 48 hours a quest to expand astronomers' known inventory of so-called exoplanets.

16 Apr 2018

BRIEF-Rocket Pharmaceuticals Reports Full-Year 2017 Results

* ROCKET PHARMACEUTICALS REPORTS FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

06 Mar 2018

Earnings vs. Estimates